Paper11533489
Duration of nuclear NF-kappaB action regulated by reversible acetylation.
Chen Lf and 3 others. Science, 2001. Cited by 1,053 papers, by iCite.
Cite this record
ConductScience Library. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Papers, record 11533489. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11533489
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics34
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Nucleus | Major topic |
| I-kappa B Proteins | Major topic |
| NF-kappa B | Major topic |
| Acetylation | |
| Acetyltransferases | |
| Active Transport, Cell Nucleus | |
| Animals | |
| COS Cells | |
| CREB-Binding Protein | |
| Cell Cycle Proteins | |
| Cell Line | |
| Cytoplasm | |
| DNA | |
| DNA-Binding Proteins | |
| HeLa Cells | |
| Histone Acetyltransferases | |
| Histone Deacetylase Inhibitors | |
| Histone Deacetylases | |
| Humans | |
| Hydroxamic Acids | |
| Mice | |
| NF-KappaB Inhibitor alpha | |
| Nuclear Proteins | |
| Phosphorylation | |
| Protein Binding | |
| Protein Transport | |
| Recombinant Fusion Proteins | |
| Trans-Activators | |
| Transcription Factor RelA | |
| Transcription Factors | |
| Tumor Necrosis Factor-alpha | |
| p300-CBP Transcription Factors | |
| p300-CBP-Associated Factor | |
| Histone Deacetylase 3 |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30MH59037 | NIMH NIH HHS | United States | P30MH059037 | PubMed and NIH |
Source NIH RePORTER
Cited by555
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,053 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42958367 | CRAT-mediated acetylcarnitine shuttling sustains p65 acetylation and NF-κB-associated radioresistance in colorectal cancer. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42958367 | PubMed |
| 42905243 | HDAC3 Inhibitor RGFP966 Enhances Memory Persistence in a Biphasic Manner and Modulates NF-kB Nuclear Localization. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42905243 | PubMed |
| 42811655 | Targeting Microglial HDAC5 Suppresses NLRP3 Inflammation via NF-κB Deacetylation to Alleviate Ischemic Brain Injury. | CNS Neurosci Ther | 2026 | https://conductscience.org/library/papers/42811655 | PubMed |
| 42747207 | Cannabidiol Ameliorates Blood-Brain Barrier Dysfunction and Inhibits Memory Astrocytes Activation in Mice With Sickness-Like Behaviors. | CNS Neurosci Ther | 2026 | https://conductscience.org/library/papers/42747207 | PubMed |
| 42699205 | Metabolite-driven protein modifications in immune signaling: from established principles to emerging pyruvylation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42699205 | PubMed |
| 42199440 | Metabolism-driven emerging acylation modifications in COPD: from elucidation of fundamental mechanisms to clinical diagnosis and treatment. | Front Immunol | 2026 | https://conductscience.org/library/papers/42199440 | PubMed |
| 42193094 | Natural Products Targeting Acetylation in Bladder Cancer: Mechanistic Basis, Therapeutic Potential, and Future Perspectives. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42193094 | PubMed |
| 42183232 | Metabolic and post-translational modifications in sepsis-associated immune dysfunction: a conceptual framework. | Front Immunol | 2026 | https://conductscience.org/library/papers/42183232 | PubMed |
| 42148116 | The long noncoding RNA lnc-FAM164A1-ACLY axis promotes pro-inflammatory responses in human primary macrophages: a systems approach. | Front Immunol | 2026 | https://conductscience.org/library/papers/42148116 | PubMed |
| 42015143 | The roles of IKKα in normal physiology and cancer. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42015143 | PubMed |
| 41749811 | NF-κB Signaling as a Central Driver of Cancer Cachexia. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41749811 | PubMed |
| 41515997 | Oral and Gut Health, (Neuro) Inflammation, and Central Sensitization in Chronic Pain: A Narrative Review of Mechanisms, Treatment Opportunities, and Research Agenda. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41515997 | PubMed |
| 41322258 | A novel RELA K119 deacetylation mediated by SIRT7 is a pivotal activator to exacerbate liver inflammation and fibrosis in teleosts. | Mar Life Sci Technol | 2025 | https://conductscience.org/library/papers/41322258 | PubMed |
| 41311406 | The epigenetic landscape of rheumatoid arthritis: Pathogenesis and drug therapeutic potentials. | Acta Pharm Sin B | 2025 | https://conductscience.org/library/papers/41311406 | PubMed |
| 41272697 | Cisplatin-mediated activation of NF-κB promotes lung cancer stem cell formation via DNA repair pathways. | J Transl Med | 2025 | https://conductscience.org/library/papers/41272697 | PubMed |
| 41236113 | NF-κB Is a Potential Therapeutic Target for Histone Deacetylase Inhibitor-Resistant Cutaneous T-Cell Lymphoma. | Cancer Sci | 2026 | https://conductscience.org/library/papers/41236113 | PubMed |
| 41225360 | Molecular regulatory mechanism of the SIRT2/NF-κB p65 signaling pathway in ferroptosis-promoted spinal cord injury repair. | BMC Neurol | 2025 | https://conductscience.org/library/papers/41225360 | PubMed |
| 41192481 | Sphingomyelin regulates astrocyte activity by regulating NF-κB signaling via HDAC1/3 expression. | J Lipid Res | 2025 | https://conductscience.org/library/papers/41192481 | PubMed |
| 40787446 | Short-chain fatty acids: key antiviral mediators of gut microbiota. | Front Immunol | 2025 | https://conductscience.org/library/papers/40787446 | PubMed |
| 40606622 | Protective effect of Salvianolic acid B against atherosclerosis: a preclinical systematic review and meta-analysis. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40606622 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| RELA | 5970 | Swiss-Prot's references | https://conductscience.org/library/genes/5970 | NCBI Gene |
| CREBBP | 1387 | PubTator's text mining | https://conductscience.org/library/genes/1387 | NCBI Gene |
| EP300 | 2033 | PubTator's text mining | https://conductscience.org/library/genes/2033 | NCBI Gene |
| HDAC3 | 8841 | PubTator's text mining | https://conductscience.org/library/genes/8841 | NCBI Gene |
| KAT2B | 8850 | PubTator's text mining | https://conductscience.org/library/genes/8850 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| NFKBIA | 4792 | PubTator's text mining | https://conductscience.org/library/genes/4792 | NCBI Gene |
| XPO1 | 7514 | PubTator's text mining | https://conductscience.org/library/genes/7514 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11533489
GET https://conductscience.org/api/papers/v1/11533489/cited_by?page=2